Literatur
Socinski MA et al. N Engl J Med. 2018;378(24):2288–301
Sandler A et al. N Engl J Med. 2006;355(24):2542–50
Crinò L et al. Lancet Oncol. 2010;11(8):733–40
Literatur
Socinski MA al. Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. N Engl J Med. 2018;378(24): 2288–301
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hammerschmidt, S. Antiangiogenese plus PD-L1-Hemmer in der Erstlinie beim nsqNSCLC erfolgreich. Info Onkol. 22, 30–31 (2019). https://doi.org/10.1007/s15004-019-6386-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15004-019-6386-3